Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB …,

As a result, the Company expects to commence patient enrollment for the Phase 1b/2a clinical trial in the first quarter of 2021. Synthetic Biologics, Inc., As a result, the Company expects to commence patient enrollment for the Phase 1b/2a clinical trial in the first quarter of 2021. Synthetic Biologics, Inc., Read More